Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protescal for Post-Caesarean Scar Prevention
NCT04951869Phase 3Completed
- Sponsor
- Hospital Canselor Tuanku Muhriz
- Start
- Apr 2017
- Primary completion
- Oct 2017
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Hypertrophic Scar (HS) and keloid (2 arms), sponsored by Hospital Canselor Tuanku Muhriz. Primary endpoints: Assessment of degree of caesarean wound healing using REEDA scale at Day 10, Assessment of Caesarean wound keloid formation & degree of scarring using Modified Vancouver Scar Scale at 3 months and 1 more. Started Apr 2017; status: completed.
02
Conditions
Hypertrophic Scar (HS)keloid
Beyond the preview
Go deeper on NCT04951869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04951869.